Assertio Holdings will release 2024 financial results on March 12, 2025, followed by a live webcast at 4:30 PM ET.
Quiver AI Summary
Assertio Holdings, Inc. announced that it will release its fourth quarter and full year 2024 financial results on March 12, 2025, after market close, followed by a live webcast of the earnings conference call at 4:30 p.m. Eastern Time. Investors can access the webcast and additional information on Assertio's investor relations website, and it is recommended to connect at least 10 minutes early for any necessary software downloads. For those opting to join via telephone, a specific dial-in number and call ID are provided. A replay of the webcast will be available shortly after the call. Assertio is a pharmaceutical company focused on marketing products related to oncology, neurology, and pain management.
Potential Positives
- Assertio Holdings, Inc. is proactively engaging with investors by announcing the release date for its fourth quarter and full year 2024 financial results, which can enhance transparency and trust.
- The scheduled live webcast for the earnings conference call demonstrates Assertio's commitment to clear communication with stakeholders, providing an opportunity for real-time engagement.
- Assertio highlights its focus on differentiated pharmaceutical products in oncology, neurology, and pain management, reinforcing its strategic position in addressing specific patient needs.
- The availability of a webcast replay allows investors and analysts to access the earnings call at their convenience, showcasing Assertio's dedication to investor engagement and accessibility.
Potential Negatives
- Timing of the financial results announcement may lead to speculation about underlying challenges or poor performance, especially as it comes after the close of the market.
- The choice to host an earnings call later than some competitors could imply a lack of readiness or transparency regarding financial performance.
FAQ
When will Assertio release its 2024 financial results?
Assertio will release its fourth quarter and full year 2024 financial results on March 12, 2025, after market close.
How can I access Assertio's earnings conference call?
You can access the live webcast and conference call details on Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx.
What time is the earnings conference call scheduled?
The earnings conference call will be hosted at 4:30 p.m. Eastern Time on March 12, 2025.
Is there a phone option for the conference call?
Yes, you can join the conference call by dialing +1-646-307-1963 with call ID 3278948.
Where can I find information about Assertio?
For more information about Assertio, you can visit their official website at www.assertiotx.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ASRT Insider Trading Activity
$ASRT insiders have traded $ASRT stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ASRT stock by insiders over the last 6 months:
- HEATHER L MASON purchased 75,000 shares for an estimated $60,000
- BRENDAN P. O'GRADY (CEO) purchased 11,706 shares for an estimated $9,950
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ASRT Hedge Fund Activity
We have seen 35 institutional investors add shares of $ASRT stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 800,000 shares (-8.9%) from their portfolio in Q4 2024, for an estimated $696,880
- UBS GROUP AG added 442,559 shares (+2586.6%) to their portfolio in Q4 2024, for an estimated $385,513
- AQR CAPITAL MANAGEMENT LLC removed 357,664 shares (-28.4%) from their portfolio in Q4 2024, for an estimated $311,561
- BANK OF NEW YORK MELLON CORP removed 289,303 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $252,011
- FIRST TRUST ADVISORS LP removed 267,269 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $315,377
- RENAISSANCE TECHNOLOGIES LLC removed 240,426 shares (-7.4%) from their portfolio in Q4 2024, for an estimated $209,435
- RUSSELL INVESTMENTS GROUP, LTD. removed 237,305 shares (-35.9%) from their portfolio in Q4 2024, for an estimated $206,716
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
LAKE FOREST, Ill., March 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.
To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx . Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-646-307-1963. The call ID is 3278948.
A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.
About Assertio
Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients through marketing such products for oncology, neurology, and pain management. To learn more about Assertio, visit
www.assertiotx.com
.
Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
[email protected]
